← 返回

高级别犬肥大细胞瘤免疫微环境的瘤间异质性

英文原题:Intertumoral heterogeneity of the immune microenvironment in high grade canine mast cell tumors.

查看英文原题

Intertumoral heterogeneity of the immune microenvironment in high grade canine mast cell tumors.

PubMed 2025/03/14(内容时间) Vet Oncol

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

我们的数据揭示了低级别和高级别 MCT 免疫 TME 的显著差异,并为进一步研究免疫检查点在犬 MCT 中潜在的预后和治疗作用提供了依据。

研究思路结论见上方概要

犬皮肤肥大细胞瘤(MCTs)是一种常见但临床上具有挑战性的肿瘤类型,因其生物学行为多变。尽管低级别MCTs的患者通常仅通过手术即可得到有效管理,但大多数高级别MCTs的犬只即使接受多模式治疗仍死于该病。对免疫肿瘤微环境(TME)的深入了解可能有助于识别新的预后和治疗靶点。

在这项研究中,我们探究了低级别和高级别MCT中TME的免疫转录谱,并量化了瘤内T细胞。选取了12只患有MCT的客户拥有犬(6只Kiupel低级别且临床行为良性,6只Kiupel高级别且临床行为侵袭性),这些犬接受了治愈意图手术。肿瘤分级由一位兽医病理学家确认。从所有肿瘤中提取RNA,随后利用NanoString犬IO panel进行免疫转录谱分析,并使用ROSALIND平台进行分析。通过CD3免疫组化染色确定T细胞密度,并在数字切片采集后使用ImageScope软件(Leica Biosystems)进行量化。进一步使用共免疫荧光对一只高级别MCT的TME中的淋巴细胞浸润进行了表征。

免疫转录谱分析鉴定出低级别与高级别MCT之间有9个差异表达基因(p-adj < 0.05)。程序性细胞死亡蛋白1(PDCD1)和诱导性T细胞共刺激配体(ICOSLG)基因表达在一部分高级别MCT中显著升高。ICOSLG表达与T细胞评分呈正相关(r s = 0.6434,p = 0.0278)。尽管低级别MCT(CD3 + 均值76.42/mm 2,SD 12 CD3 + /mm 2)与高级别MCT(CD3 + 均值129.1/mm 2,SD 96.06 CD3 + /mm 2)之间的T细胞密度无显著差异,但高级别MCT中T细胞密度的变异程度大于低级别MCT(p = 0.0059)。对一例伴有显著T细胞浸润的高级别MCT进行免疫荧光检测,发现T细胞和B细胞呈有组织的聚集,与三级淋巴结构(TLS)一致。

展开英文摘要原文

Canine cutaneous mast cell tumors (MCTs) are a common, yet clinically challenging tumor type given their variable biological behavior. Although patients with low grade MCTs can often be effectively managed with surgery alone, most dogs with high grade MCTs succumb to their disease despite multimodal therapy. An improved understanding of the immune tumor microenvironment (TME) may help identify novel prognostic and therapeutic targets.

In this study, we interrogated the immune transcriptional profiles of the TME in low and high grade MCTs, and quantified intratumoral T cells. Twelve client-owned dogs with MCTs (6 Kiupel low grade with clinically benign behavior and 6 Kiupel high grade with clinically aggressive behavior) that underwent curative-intent surgery were selected. Tumor grade was confirmed by a single veterinary pathologist. RNA was extracted from all tumors followed by immune transcriptional profiling utilizing the NanoString Canine IO panel and analysis using the ROSALIND platform. T cell density was determined by immunohistochemical staining for CD3 and quantified using ImageScope software (Leica Biosystems) following digital slide capture. Lymphocytic infiltrate was further characterized in the TME of one high grade MCT using co-immunofluorescence.

Immune transcriptional profiling identified 9 differentially expressed genes between low and high grade MCTs (p-adj < 0.05). Programmed cell death protein 1 ( PDCD1 ) and inducible T-cell costimulator ligand ( ICOSLG ) gene expression were significantly higher in a subset of high grade MCTs. ICOSLG expression positively correlated with T cell score (r s = 0.6434, p = 0.0278). Although the T cell density was not significantly different between low (mean of 76.42 CD3 + /mm 2 , SD 12 CD3 + /mm 2 ) and high grade MCTs (mean of 129.1 CD3 + /mm 2 , SD 96.06 CD3 + /mm 2 ), greater variation of T cell densities was observed across high grade MCTs compared to low grade ( p = 0.0059). Immunofluorescence of one high grade MCT with marked T cell infiltration revealed organized aggregates of T and B cells consistent with tertiary lymphoid structures (TLS).

Our data revealed significant differences in the immune TME of low and high grade MCTs and provides rationale to further investigate potential prognostic and therapeutic roles of immune checkpoints in canine MCTs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s44356-025-00020-9.

论文信息

作者
Bardales KL、Jiang L、Radaelli E、Assenmacher CA、Lenz JA、Atherton MJ
单位
Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA USA.United States
期刊
Veterinary oncology (London, England)2025
原文标识
PubMed 40093350 · DOI 10.1186/s44356-025-00020-9